Saturday 17 October 2026
Export ALVO’s income statement to Excel — free account
Alvotech
ALVO Healthcare Drug Manufacturers Specialty & Generic
Alvotech’s revenue for fiscal 2025 (year ended December 2025) was $586.3 million, up 19.7% from fiscal 2024. In the quarter to June 2026, revenue grew 2,311.0%, EPS fell 99.5%, free cash flow fell 496.6% and total debt rose 16.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
5.00
0.31
−5.84%
Follow ALVO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | 5 | — |
| 0.00% | 0.00% | 101.38% | 0.00% | ||
| 0.00% | 0.00% | (22.23%) | 0.00% | ||
ROIC |
0.00% | 0.00% | (8.07%) | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | (53.26%) | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 60.34 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | (0.54) | 0.00 | |
Free Cash Flow |
(274.92) | — | (157.95) | (211.69) | |
Capital Expenditures |
(158.28) | — | (178.53) | (199.93) | |
| Other line items | |||||
Cash ROIC |
(27.76%) | 0.00% | (14.48%) | (16.84%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 2.70 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 2.03 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.91 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 212.60 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 495.34 | 0.00 | |
Tax Rate |
— | — | (0.12) | — | |
Research and Development Expense of Revenue |
— | — | 56.53% | — | |
Selling, General and Administrative Expense of Revenue |
— | — | 26.06% | — | |
Share Based Compensation of Revenue |
0.00% | — | 4.07% | 0.00% | |
Interest Coverage |
— | — | (0.33) | — | |
Operating CF/Net income |
0.00 | — | (0.07) | 0.00 | |
Depreciation/Fixed assets |
0.19 | 0.00 | 0.15 | 0.15 | |
Capex/Depreciation |
(2.34) | — | (3.25) | (3.51) | |
Revenue per Share |
— | — | 1.00 | — | |
Operating CF per Share |
0.00 | — | 0.07 | 0.00 | |
Capex per Share |
0.00 | — | (0.61) | 0.00 | |
Capex to Sales |
0.00 | — | 0.61 | 0.00 |
Columns are period end dates